Zhongyuan Biotech Accesses The US Capital Market

• Date：2021-05-23

• By：Zhong Yuan Biotech

On June 29, 2020 EDT, The Securities and Exchange Commission (" SEC ") approved and declared effective the Prospectus for the U.S. Initial public Offering of ZHONG YUAN BIO-TECHNOLOGY HOLDINGS LIMITED.

In this IPO, the company is public offering 2,000,000 to 4,000,000 shares, and this stock issuance will only be conducted in the form of the Prospectus registered by the SEC. Before registering or qualifying under the securities laws of the jurisdiction, this press release does not constitute an illegal sale or solicitation to purchase company securities in any jurisdiction or an invitation to offer.